Two Sigma Securities’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,299
Closed -$220K 1768
2025
Q4
$220K Buy
+14,299
New +$157K 0.03% 809
2025
Q2
Sell
-25,622
Closed -$332K 1630
2025
Q1
$332K Buy
+25,622
New +$339K 0.05% 535
2024
Q4
Sell
-11,612
Closed -$129K 2071
2024
Q3
$129K Buy
+11,612
New +$128K ﹤0.01% 2233
2023
Q3
Sell
-16,678
Closed -$215K 3047
2023
Q2
$215K Buy
+16,678
New +$190K ﹤0.01% 2158
2017
Q3
Sell
-16,495
Closed -$159K 981
2017
Q2
$159K Buy
+16,495
New +$107K 0.03% 602
2017
Q1
Sell
-31,848
Closed -$126K 934
2016
Q4
$126K Buy
31,848
+20,874
+190% +$153K 0.04% 531
2016
Q3
$115K Buy
+10,974
New +$158K 0.04% 508

Other funds holding DVAX

Two Sigma Securities's DVAX Position: Q1 2026 in Review

Two Sigma Securities sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 14,299 shares — an estimated $220K sold.

Two Sigma Securities first reported a position in DVAX in Q3 2016 and held it in 7 quarters. The position peaked at $332K in Q1 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Two Sigma Securities reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 14,299 Dynavax Technologies shares in Q1 2026, an estimated $220K.
  • Two Sigma Securities first reported a position in Dynavax Technologies in Q3 2016 and held it in 7 quarters.
  • Two Sigma Securities's Dynavax Technologies position peaked at $332K in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.